Curis ( CRIS) is a drug discovery and development company that is committed to leveraging signaling pathway drug technologies in seeking to develop next generation network-targeted cancer therapies. This stock is trading up 5.3% to $4.22 in recent trading. Today's Range: $4.06-$4.23 52-Week Range: $2.87-$5.65 Volume: 211,000 Three-Month Average Volume: 411,944 From a technical perspective, CRIS is trending higher here with light volume as it finds some buying interest around some previous support levels near $4. This move is starting to push CRIS within range of triggering a near-term breakout trade. That trade will hit once CRIS manages to take out some near-term overhead resistance at $4.35 to $4.44, and then once it clears its 200-day at $4.67 with high volume. Traders should now look for long-biased trades in CRIS once it manages to sustain a move or close above those levels with volume that's near or above 411,944 shares. If that breakout triggers soon, then CRIS will have a great chance of re-testing or possibly taking out its next major overhead resistance levels at $5.16 to $5.50. To see more stocks under-$10 that are making notable moves higher today, check out the Stocks Under $10 Moving Higher portfolio on Stockpickr. -- Written by Roberto Pedone in Winderemere, Fla.